HHS to stop funding ‘dangerous’ life sciences research
Paige Twenter / beckershospitalreview - The federal government will stop funding what it determines to be “dangerous” gain-of-function research conducted in the U.S. and abroad after implementing a new policy. The “Policy for Stopping High-Risk Life Sciences Research” lands during broader uphea…
AI Summary: The federal government announced a new policy curbing federal funding for defined categories of high‑risk life‑sciences research, citing biosafety and biosecurity concerns. The move pauses support for experiments judged to pose elevated pandemic or containment risks, sparking debate about how to balance oversight, scientific progress and public safety without stifling useful innovation.
CMS to end subsidies for Medicare drug plan premiums
Emily Olsen / healthcaredive - The CMS said the program, which went into effect last year to stabilize Part D premiums and enrollment, isn’t needed anymore. One researcher said some enrollees could see higher premium increases in 2027 as a result.
AI Summary: CMS will terminate its Part D premium stabilization subsidy, a program that helped blunt year-to-year premium swings for Medicare drug plans. The move removes a federal backstop aimed at keeping beneficiaries’ premiums lower, likely pushing costs onto enrollees and plan sponsors while igniting concerns about affordability for seniors and people on fixed incomes.
As Cyclospora Cases Climb, FDA Official Says Food Supply Is Safe
Julie Creswell / nytimes - The acting deputy commissioner for food said the agency was taking action even though finding the root cause of the outbreaks is difficult.
AI Summary: Health authorities are tracking a rising number of cyclospora infections while stressing the overall safety of the food supply. Officials urged vigilance and proper food handling, noting some patients experience severe gastrointestinal illness. Public health experts warned that recurring outbreaks raise concerns about vulnerabilities in produce safety and monitoring systems.
- Iceberg lettuce link: multistate traceback and restaurant impacts (4)
- Public health strain: FDA reassures, experts warn, symptoms and travel (5)
- Scope and toll: exploding cases, hospitalizations and first U.S. deaths (6)
- All Other Stories
Iceberg lettuce link: multistate traceback and restaurant impacts
Public health strain: FDA reassures, experts warn, symptoms and travel
Scope and toll: exploding cases, hospitalizations and first U.S. deaths
All Other Stories
Centene boosts guidance amid $1.1B Q2 profit, ACA membership drop
Elizabeth Casolo / beckershospitalreview - Centene brought in a $1.1 billion profit for the second quarter of 2026, up from a $253 million loss at the same time last year, according to the company’s July 28 earnings report. Total revenue approached $53.6 billion for the quarter, up nearly 10% year…
AI Summary: Centene reported a dramatic Q2 turnaround, posting about $1.1 billion in profit and raising its 2026 guidance despite an ACA membership decline. Executives credited improved margins and operational adjustments for the rebound, signaling a healthier financial posture as the company navigates policy and enrollment headwinds.
Prediction Market Betting on Drug Trials and Approvals Sparks Concern About Undermining Research
Rebecca Robbins / nytimes - Prediction markets on Kalshi and Polymarket now let people wager money on drug approvals. Kalshi also plans to allow bets on clinical trial results.
AI Summary: Betting platforms have started offering markets on clinical trial outcomes and FDA decisions, stirring alarms among regulators and researchers. Critics warn these markets could incentivize insider trading, leak-sensitive information, or distort trial conduct, prompting calls for oversight and clearer rules to protect scientific integrity and participant safety — because apparently Wall Street needed another hobby.
Ebola Outbreak Surpasses 3,000 Cases as First Human Vaccine Trial for Rare Bundibugyo Virus Begins
discovermagazine - Learn how a rare Ebola strain has fueled one of the largest outbreaks on record and what the first human vaccine trial could mean for containing the outbreak.
AI Summary: An Ebola outbreak in eastern DR Congo has surpassed 3,000 reported cases and is poised to become the second-largest on record. Authorities have launched the first human vaccine trial targeting the Bundibugyo strain while laboratory tests show stockpiled Ebola vaccines generate antibodies against Bundibugyo, intensifying both response operations and urgent vaccine research.
- Race for a Bundibugyo vaccine: trials and lab progress (5)
- Strained response: strikes, unpaid staff, funding and leadership shake-up (5)
- Surging outbreak: cases, deaths and WHO alarm (7)
- All Other Stories
Race for a Bundibugyo vaccine: trials and lab progress
Strained response: strikes, unpaid staff, funding and leadership shake-up
Surging outbreak: cases, deaths and WHO alarm
All Other Stories
US court rules abortion pill restrictions 'unlawful'
medicalxpress - A federal court in Virginia has ruled that restrictions imposed by the U.S. drug regulator on the abortion pill mifepristone are "unlawful" and ordered the Trump administration to reconsider them.
AI Summary: A U.S. court ruled recent restrictions on the abortion pill unlawful, reaffirming FDA regulatory standards and restoring broader access. Industry groups filed briefs backing FDA oversight, warning that legal uncertainty would harm patients and research. The ruling calms access for now while legal and policy debates continue.
Live attenuated vaccines alone or in combination with an adenovirus-based vaccine protect mice lacking IFN-γ against pneumonic plague
Emily K. Hendrix, Jian Sha, Paul B. Kilgore, Blake H. Neil, Atul K. Verma, Heidi Spratt, Ashok K. Ch / science - Science Translational Medicine, Volume 18, Issue 859, July 2026.
AI Summary: Preclinical work shows that a live attenuated vaccine, alone or combined with an adenovirus vector, protected mice lacking key interferon‑gamma defenses from pneumonic plague. The strategy delivered surprising protection in immunocompromised models, suggesting a potential path forward for vaccines designed to work even when classical immune pathways are impaired.
DHS finalizes 4-year visa limit for international physician training
Paige Twenter / beckershospitalreview - On July 17, the Department of Homeland Security finalized a rule capping U.S. stays for international students and exchange visitors at four years, ending the open-ended “duration of status” framework for medical trainees. Here are six things to know: 1. …
AI Summary: The Department of Homeland Security finalized new visa policies that alter the duration and structure of certain training‑related visas for international physicians, decoupling program length from visa terms. The changes aim to tighten immigration controls while raising concerns about workforce planning and the pipeline of internationally trained clinicians in U.S. health systems.
AHRQ terminates dozens of patient care research grants: Report
Elizabeth Gregerson / beckershospitalreview - HHS’ Agency for Healthcare Research and Quality has begun to terminate funding for research related to strengthening patient safety, care delivery, clinical practice and policy, and workforce training, according to a July 16 report from AcademyHealth. Aca…
AI Summary: The Agency for Healthcare Research and Quality has discontinued dozens of active research awards focused on patient care, citing programmatic changes and funding shifts. The abrupt terminations leave investigators scrambling and could slow progress on projects aimed at improving clinical practice and outcomes—proof that research pipelines are only as sturdy as their funding lines.
Molina Healthcare plans more marketplace exits as ACA segment falters
fiercehealthcare - Molina Healthcare is planning further reductions in its marketplace business as high costs continue to pressure that segment, the company's top brass told investors on Thursday morning.
AI Summary: Molina Healthcare announced plans to withdraw from additional Affordable Care Act marketplaces, citing financial challenges and market pressures. The move signals growing instability for some insurers in the ACA exchange space and could limit options for consumers in affected regions, while reigniting debates about market design and access.
- Hospitals and employers feel squeeze as uninsured rates climb (4)
- Insurers retreat from ACA exchanges, sparking debate over causes (4)
Hospitals and employers feel squeeze as uninsured rates climb
Insurers retreat from ACA exchanges, sparking debate over causes
US actions harm global efforts to prevent and treat HIV in dozens of countries, new report says
medicalxpress - The Trump administration's disruptions to a global AIDS relief program have forced organizations to close clinics, lay off staff and cut services, seriously impeding efforts to prevent and treat the disease in dozens of countries, a new report released Tu…
AI Summary: A new analysis concludes recent U.S. policy shifts have weakened international HIV prevention and treatment initiatives, disrupting funding flows and partnership stability. Public health experts caution the changes could reverse progress in vulnerable regions, urging policymakers to recalibrate support to sustain global gains against HIV/AIDS.
Children's cereals promise breakfast fun and nutrition, but are still high in sugar
medicalxpress - Many of us have grown up hearing the mantra that breakfast is the most important meal of the day, yet children's cereals fall short of that standard. That is the takeaway of new research analyzing child-targeted cereals in Canada.
AI Summary: Two investigative reports show major children's breakfast cereals remain high in added sugars despite branding that implies nutrition and fun. Public health advocates warn the products contribute to unhealthy diets in kids and call for clearer labeling and stricter marketing standards to parents and regulators.
Key Republican Senator Says He Will Support Erica Schwartz for C.D.C. Director
Sheryl Gay Stolberg / nytimes - Senator Bill Cassidy, who is believed to hold the deciding vote in the Senate health committee for Dr. Erica Schwartz’s confirmation, had declined for days to say whether he would back her.
AI Summary: A leading Republican senator announced support for Dr. Erica Schwartz’s nomination to lead the CDC, bolstering bipartisan momentum amid a contentious confirmation process. The endorsement could smooth Senate consideration by narrowing opposition and signaling pragmatic cooperation on public health leadership.
6-year-old in China dies after experimental treatment, investigation finds, raising questions about the country's gene therapy regulations
livescience - A young girl in China died after being given an experimental gene therapy intended to treat a neurodevelopmental syndrome, an investigation by Science and Retraction Watch revealed.
AI Summary: An investigation found a six‑year‑old patient died following an experimental gene‑editing treatment in China, and that the fatality was not promptly disclosed. The case has reignited scrutiny of the country’s gene therapy oversight and raised urgent questions about trial transparency, consent and regulatory enforcement.
1.6 Million Egg Cartons Are Recalled Over Salmonella Risk
Alena Cerro / nytimes - The voluntary recall included eggs produced in Texas and sold under several brand names in six states, the Food and Drug Administration said.
AI Summary: The USDA-ordered recall removes roughly 1.6 million cartons (about 1.6 million dozen) of eggs after Salmonella contamination concerns surfaced. Retailers have been instructed to pull affected lots and consumers advised to discard or return suspect products. Regulators and producers are scrambling to trace the source and contain potential outbreaks.
GLP-1s tied to 37% higher hair loss risk, study finds
Mackenzie Bean / beckershospitalreview - GLP-1 receptor agonists carry a higher risk of hair loss than other diabetes medications, according to a study published July 22 in The BMJ. Researchers at Philadelphia-based Penn Medicine used EHR data to compare adults with Type 2 diabetes who started G…
AI Summary: A series of new analyses tie GLP‑1 diabetes and obesity drugs to a measurable rise in hair loss reports, with varying risk estimates prompting doctors to warn patients and researchers to dig deeper. Clinicians urge monitoring and clearer guidance as these widely used medications shift from metabolic miracles to potential cosmetic headaches.
OpenAI makes Health in ChatGPT widely available, moving deeper into consumer health
fiercehealthcare - OpenAI on Thursday made its Health in ChatGPT feature broadly available, enabling U.S. users to connect its artificial intelligence chatbot with medical records and wellness apps.
AI Summary: OpenAI has expanded the Health feature in ChatGPT to all US users, embedding symptom guidance, medication information and basic health tools into its consumer chat product. The rollout marks a deeper push into consumer health — offering easy access to medical-ish advice while predictably inviting scrutiny over safety, accuracy and data handling.
ChatGPT Health rollout and product details
Safety, liability and systemic concerns
Measles cases set 35-year US record with months to go in 2026
medicalxpress - The United States has recorded more measles cases this year than in any year since 1991, with more than five months still left on the calendar.
AI Summary: Measles has surged to levels not seen in decades, prompting clinicians to describe chaotic front-line care and mounting pediatric distress. Public-health officials and hospitals are managing outbreaks, vaccination gaps and increased hospitalizations, while providers urge broader immunization and rapid containment to blunt what is becoming a national public-health headache.
Walid Kamoun: Breakthroughs Begin With the Right Questions and the Courage to Pursue Them
oncodaily - Walid Kamoun, Vice President, Global Head of R/D Oncology at Servier, shared The Nobel Prize’s post on LinkedIn, adding: “In this inspiring video, Tasuku Honjo reminds us that breakthrough innovation […]
AI Summary: Health officials confirmed a second fatality tied to a Legionnaires' disease outbreak in New York City, prompting intensified environmental testing and public‑health interventions. Authorities are tracing sources, inspecting water systems and issuing guidance to vulnerable populations while hospitals manage a surge of severe respiratory infections.